GlassScriptPhysician profile
Moshe Shapiro
NPI 1417290974
$5,007.53
in general payments reported to CMS, 2019-2025
26 companies · $1,302 in 2025
The $1,302 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $693 · 2020: $353 · 2021: $542 · 2022: $423 · 2023: $1,325 · 2024: $370 · 2025: $1,302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,643 · Travel and Lodging: $1,353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,643.47 |
| Travel and Lodging | $1,353.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $931.10 | 2022-2023 | Aquabeam Robotic System |
| Coloplast Corp | $909.83 | 2019-2025 | Porges Coloplast |
| Boston Scientific Corporation | $846.11 | 2019-2025 | General - Therapies, Lithoclast |
| Sumitomo Pharma America, INC. | $557.31 | 2023-2025 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $223.31 | 2019-2025 | Xtandi, Myrbetriq |
| Dendreon Pharmaceuticals LLC | $185.43 | 2021-2025 | Provenge |
| Myovant Sciences INC. | $173.20 | 2022 | |
| Metuchen Pharmaceuticals | $159.44 | 2020 | |
| Endo Pharmaceuticals INC. | $140.37 | 2020-2023 | Xiaflex |
| Teleflex LLC | $128.13 | 2021 | |
| Rochester Medical Corporation | $104.13 | 2020-2021 | |
| Medtronic USA, INC. | $96.07 | 2020 | |
| Medtronic, INC. | $78.42 | 2022 | |
| Merck Sharp & Dohme LLC | $65.93 | 2022-2025 | Lynparza, Keytruda |
| Tempus Ai, INC | $50.71 | 2025 | Xt Cdx |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $49.29 | 2022-2023 | Botox |
| Ambu INC. | $42.10 | 2021-2024 | |
| Accord Healthcare, INC. | $42.03 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $41.76 | 2021-2022 | |
| Pfizer INC. | $35.63 | 2020-2025 | |
| Olympus America INC. | $32.19 | 2024-2025 | Itind System |
| Bayer Healthcare Pharmaceuticals INC. | $28.47 | 2023 | |
| Janssen Biotech, INC. | $25.70 | 2022 | |
| Urogen Pharma, INC. | $22.99 | 2022 | |
| Ethicon US, LLC | $20.28 | 2025 | Vistaseal, Surgicel Nu-Knit, Dermabond Prineo |
| Travere Therapeutics, INC. | $17.60 | 2020-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moshe Shapiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.